A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different Sites

Clinical trial NCT06086912 · COMPLETED

Trial details

NCT number: NCT06086912
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-11-07
Primary completion: 2023-12-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.